Pay in 4 interest-free payments of $34.75 Learn more
Ships within 48 hours · Estimated delivery Oct 20 - Oct 25
Dynamic acetylation of all lysine-4 trimethylated histone H3 is evolutionarily conserved and mediated by p300/CBP
SCH 51344 inhibits ras transformation by a novel mechanism
33(2):300-9
It inhibited the activity of human PRC2-containing wild-type EZH2 with an inhibition constant (Ki) value of 2
18(15):4104-13
IDH-C227 - IDH1 Inhibitor. CAS# 1355324-14-9 0232 Dynamic acetylation of all lysine-4IDH C227, CAS No. 1355324 14 9, is a potent and selective IDH1 R132H inhibitor first reported in patent WO2012009678. It can inhibit the enzymatic activity of IDH1 R132H in vitro with an IC50 < 0. 1 M, and 2 HG production in HT1080 and U87MG cells with IC50 < 0. 25 M. Because the mutated form of IDH1 produces the metabolite, 2 hydroxyglutarate (2HG), which may contribute to the formation and malignant progression of gliomas as well as other forms of
US$ 622.00
US$ 177.00
US$ 214.19
US$ 272.67
US$ 197.42
US$ 935.00
US$ 352.00
US$ 197.42
US$ 117.30
US$ 271.23
US$ 147.58
US$ 197.42
US$ 352.00
US$ 138.60
US$ 126.47
US$ 141.26
US$ 305.21
US$ 137.54
US$ 147.58
US$ 262.76